These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9790536)

  • 1. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles.
    Westra WH; Sidransky D
    J Natl Cancer Inst; 1998 Oct; 90(20):1500-1. PubMed ID: 9790536
    [No Abstract]   [Full Text] [Related]  

  • 2. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants.
    Wenig BM
    Mod Pathol; 2002 Mar; 15(3):229-54. PubMed ID: 11904340
    [No Abstract]   [Full Text] [Related]  

  • 3. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of head and neck cancer: current status and future prospects.
    Jain S; Khuri FR; Shin DM
    Curr Probl Cancer; 2004; 28(5):265-86. PubMed ID: 15375804
    [No Abstract]   [Full Text] [Related]  

  • 5. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
    Cohen EE
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new marker determining clonal outgrowth.
    Mao L
    Clin Cancer Res; 2002 Jul; 8(7):2021-3. PubMed ID: 12114399
    [No Abstract]   [Full Text] [Related]  

  • 8. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck.
    Ha PK; Pilkington TA; Westra WH; Sciubba J; Sidransky D; Califano JA
    Int J Cancer; 2002 Dec; 102(6):615-7. PubMed ID: 12448003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
    Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
    Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic progression model for head and neck cancer: implications for field cancerization.
    Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
    Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of biomarkers in head and neck cancer.
    Chang SS; Califano J
    J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on "the flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma" [Kamal-Eldin Ahmed Abou-Elhamd and Tito Naeem Habib. Oral Oncol 2007;43(4):366-72].
    Gandolfo S; Pentenero M; Demurtas A; Navone R
    Oral Oncol; 2008 Jan; 44(1):100-1; author reply 102. PubMed ID: 17714978
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.
    Voravud N; Shin DM; Ro JY; Lee JS; Hong WK; Hittelman WN
    Cancer Res; 1993 Jun; 53(12):2874-83. PubMed ID: 8504429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
    Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
    Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].
    Soria JC
    Bull Cancer; 2000 Jun; 87(6):446. PubMed ID: 10903785
    [No Abstract]   [Full Text] [Related]  

  • 19. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
    Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.